GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » EV-to-EBIT

MicroPort NeuroTech (HKSE:02172) EV-to-EBIT : 21.91 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MicroPort NeuroTech's Enterprise Value is HK$3,966.8 Mil. MicroPort NeuroTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil. Therefore, MicroPort NeuroTech's EV-to-EBIT for today is 21.91.

The historical rank and industry rank for MicroPort NeuroTech's EV-to-EBIT or its related term are showing as below:

HKSE:02172' s EV-to-EBIT Range Over the Past 10 Years
Min: 20.71   Med: 54.38   Max: 153.88
Current: 21.91

During the past 5 years, the highest EV-to-EBIT of MicroPort NeuroTech was 153.88. The lowest was 20.71. And the median was 54.38.

HKSE:02172's EV-to-EBIT is ranked worse than
58.09% of 451 companies
in the Medical Devices & Instruments industry
Industry Median: 19.7 vs HKSE:02172: 21.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MicroPort NeuroTech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$6,103.0 Mil. MicroPort NeuroTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil. MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.97%.


MicroPort NeuroTech EV-to-EBIT Historical Data

The historical data trend for MicroPort NeuroTech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech EV-to-EBIT Chart

MicroPort NeuroTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - 115.62 33.71

MicroPort NeuroTech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial - - 115.62 - 33.71

Competitive Comparison of MicroPort NeuroTech's EV-to-EBIT

For the Medical Devices subindustry, MicroPort NeuroTech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroTech's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's EV-to-EBIT falls into.



MicroPort NeuroTech EV-to-EBIT Calculation

MicroPort NeuroTech's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3966.828/181.033
=21.91

MicroPort NeuroTech's current Enterprise Value is HK$3,966.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroTech  (HKSE:02172) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MicroPort NeuroTech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=181.033/6102.95492
=2.97 %

MicroPort NeuroTech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$6,103.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroTech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroTech (HKSE:02172) Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines